No products in the cart.
Description
PRODUCT DESCRIPTION:
Doxorubicin is a widely used cytotoxic anthracycline antibiotic with broad-spectrum antitumor activity.
It functions by intercalating DNA strands and inhibiting topoisomerase II, thereby preventing replication and transcription in rapidly dividing cancer cells.
This product is offered in sterile Pre-Filled Syringe (PFS) format, ensuring safe, convenient, and contamination-free administration, ideal for high-compliance institutional settings and hospital-based chemotherapy protocols.
Formulation & Presentation:
- Dosage Form: Aqueous Sterile Injectable (Sterile solution) – Pre Filled Syringe
- Presentation: Both in Lyophilized & Pre-Filled Syringe (customizable as per market demand)
- Available Strengths:
- 10 MG/ 5 ML PFS
- 50 MG/25 ML PFS
- 10 MG (Lyophilized)
- 50 MG (Lyophilized)
- Route of Administration: Intravenous or as per clinical indication and severity. Reconstituted as per protocol Intravenous infusion. To be administered under supervision of a qualified oncologist. (As per physician’s discretion or decision)
Therapeutic Indications:
- Breast cancer
- Bladder cancer
- Ovarian carcinoma
- Lymphomas (Hodgkin and non-Hodgkin)
- Leukemias (AML, ALL)
- Soft tissue and bone sarcomas
- Small cell lung cancer
- Thyroid cancer
Side Effects:
- COMMON:
- Nausea and vomiting
- Hair loss (alopecia)
- Mucositis
- Myelosuppression
- Skin flushing during infusion
- SERIOUS (RARE):
- Cardiotoxicity (cumulative dose-related)
- Extravasation-related tissue necrosis
- Secondary leukemia (long-term risk)
- Severe neutropenia
- Hepatic impairment in susceptible patients
- PRECAUTIONS:
- Baseline and periodic cardiac function monitoring (LVEF) advised
- Use central line for administration to avoid local tissue damage
- Monitor CBC, liver enzymes, and renal function before each cycle
- Not recommended in pregnant or breastfeeding women
- Avoid exceeding cumulative lifetime dose (>550 mg/m² in adults)
Be the first to review “Doxorubicin 10 MG/5 ML, 50 MG/25 ML Pre-Filled Syringe”
TECHNICAL INFORMATION
Product Specifications
- HSN Code: To be assigned per international classification standards & import jurisdiction
- Weight: Approx. 40g per Carton (With Packaging)
- Dimensions: (15 x 1 x 8 CMS)
- Shelf Life: 24 to 36 months under recommended storage conditions from date of manufacture or as per label specifications
- Storage: Store below 2°C–8°C (Do not freeze). Requires cold-chain logistics. Protect from moisture and direct sunlight. Use strictly as per label guidelines.
Regulatory Status & Supply Information
- Regulatory Status: WHO-GMP Compliant Manufacturing. Further certifications available on request
- Exports Ready Dossiers: Dossier Available (CTD/eCTD formats)
- Stability: Compliant
- MOQ: Negotiable, based on market & registration status
- Export Options: Available for private label, institutional supply, or branded export
Who Should Source This Product?
- Cancer care institutions & government hospitals with active oncology protocols
- National health authorities & MoH buyers requiring GMP-compliant chemotherapy injectables
- NGOs and humanitarian healthcare providers active in cancer treatment missions
- Distributors serving oncology-focused procurement in LATAM, Africa, and South Asia
- Tender participants and group purchase organizations seeking ready regulatory support
Why Source from PHARMET?
- Single-window sourcing for diverse pharma needs
- Export-ready documentation & regulatory support
- Adaptable documentation support for effective registration
- Trusted consortium network simplifying India’s pharma supply chain
- Multiple approved manufacturers for best fit in import country
- Network of audited, compliant manufacturers across India
- Customizable & flexible branding, packaging & formulation options
- End-to-end logistics flexibility & support
- Deep expertise in exporting specialty injectables & oncology products
Contact Details
- Email: hello@pharmet.io
- Phone/WhatsApp: +91 9999091881
- Website: www.pharmet.io
Reviews
There are no reviews yet.